| |

Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
The safety testing of cell substrates for the presence of viruses in biotechnology products is an important issue and is required by regulatory agencies world-wide.
|
Back to In Vivo Testing
BioReliance offers in vivo potency assays and endpoints can include biochemical, ELISA and HPLC.
|  | |
|